Cargando…

Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

In follicular lymphoma (FL), progression of disease ≤24 months (POD24) has emerged as an important prognostic marker for overall survival (OS). We aimed to investigate survival more broadly by timing of progression and treatment in a national population-based setting. We identified 948 stage II-IV i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weibull, Caroline E., Wästerlid, Tove, Wahlin, Björn Engelbrekt, Andersson, Per-Ola, Ekberg, Sara, Lockmer, Sandra, Enblad, Gunilla, Crowther, Michael J., Kimby, Eva, Smedby, Karin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953041/ https://www.ncbi.nlm.nih.gov/pubmed/36844185 http://dx.doi.org/10.1097/HS9.0000000000000838

Ejemplares similares

Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy
por: Junlén, Henna-Riikka, et al.
Publicado: (2020)

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
por: Harrysson, Sara, et al.
Publicado: (2021)

Excellent survival after R‐Hyper‐CVAD in hospitalized patients with high‐risk large B‐cell lymphoma: The Karolinska experience
por: Sonnevi, Kristina, et al.
Publicado: (2021)

Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study
por: Wästerlid, Tove, et al.
Publicado: (2021)

Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population‐based study of 736 patients
por: Harrysson, Sara, et al.
Publicado: (2022)

Sex differences in lymphoma incidence and mortality by subtype: A population‐based study
por: Radkiewicz, Cecilia, et al.
Publicado: (2022)

Entourage: the immune microenvironment following follicular lymphoma
por: Wahlin, B E, et al.
Publicado: (2012)

Splenic marginal zone lymphoma in Sweden 2000–2020: Increasing rituximab use and better survival in the elderly
por: Junlén, Henna‐Riikka, et al.
Publicado: (2023)

Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
por: Ekberg, Sara, et al.
Publicado: (2022)

Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study
por: Wästerlid, Tove, et al.
Publicado: (2020)

Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
por: Enqvist, Monika, et al.
Publicado: (2019)

Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study
por: Joelsson, Joel, et al.
Publicado: (2022)

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017
por: Albertsson-Lindblad, Alexandra, et al.
Publicado: (2021)

Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission
por: Ekberg, Sara, et al.
Publicado: (2022)

Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach
por: Rodríguez Ruiz, Núria, et al.
Publicado: (2022)

The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome
por: Noring, Kristina, et al.
Publicado: (2021)

Hodgkin lymphoma – a survey of children and adolescents treated in Sweden 1985–2009
por: Englund, Annika, et al.
Publicado: (2015)

Real‐world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000–2014, focusing on patients aged >60 years
por: Wahlin, Björn Engelbrekt, et al.
Publicado: (2021)

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
por: Entrop, Joshua P., et al.
Publicado: (2022)

The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994–2016
por: Carlsten, Mattias, et al.
Publicado: (2019)

Checkpoint CD47 expression in classical Hodgkin lymphoma
por: Gholiha, Alex Reza, et al.
Publicado: (2022)

Application of precision medicine in clinical routine in haematology—Challenges and opportunities
por: Wästerlid, Tove, et al.
Publicado: (2022)

P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival
por: Baech, Joachim, et al.
Publicado: (2022)

The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
por: Tesfa, Daniel, et al.
Publicado: (2021)

Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features
por: Wasik, Agata M., et al.
Publicado: (2014)

Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation
por: Lorenz, Fryderyk, et al.
Publicado: (2015)

Age is the most important predictor of survival in diffuse large B‐cell lymphoma patients achieving event‐free survival at 24 months: a Swedish population‐based study
por: Abu Sabaa, Amal, et al.
Publicado: (2021)

A meta-analysis of genome-wide association studies of follicular lymphoma
por: Skibola, Christine F, et al.
Publicado: (2012)

A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival
por: Baecklund, Fredrik, et al.
Publicado: (2014)

Marginal zone lymphoma
por: Kimby, Eva
Publicado: (2018)

High risk of cardiovascular side effects after treatment of Hodgkin’s lymphoma – is there a need for intervention in long-term survivors?
por: Andersson, Anne, et al.
Publicado: (2021)

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment
por: Stevens, Wendy B. C., et al.
Publicado: (2023)

Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data
por: Syriopoulou, Elisavet, et al.
Publicado: (2022)

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma
por: Nikkarinen, Anna, et al.
Publicado: (2023)

Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study
por: Haider, Zahra, et al.
Publicado: (2023)

Solidarity or self-interest? Public opinion in relation to alcohol policies in Sweden
por: Karlsson, David, et al.
Publicado: (2020)

Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project
por: Jerkeman, Mats, et al.
Publicado: (2023)

Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
por: Mattsson Ulfstedt, Johan, et al.
Publicado: (2021)

Follicular Lymphoma
por: Yavaşoğlu, İrfan
Publicado: (2015)

Follicular lymphoma
por: Leich, Ellen
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bub3odjkgeirvtjuos4g6otukt